BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30418587)

  • 1. Persistent Dyslipidemia in Patients With Hypothyroidism: A Good Marker for Personalized Replacement Therapy?
    Biondi B
    J Clin Endocrinol Metab; 2019 Feb; 104(2):624-627. PubMed ID: 30418587
    [No Abstract]   [Full Text] [Related]  

  • 2. Design of the Optimal Trial of Combination Therapy.
    Cappola AR
    Front Endocrinol (Lausanne); 2020; 11():168. PubMed ID: 32318021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Calissendorff J
    Lakartidningen; 2019 Jul; 116():. PubMed ID: 31334815
    [No Abstract]   [Full Text] [Related]  

  • 4. ITALIAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS STATEMENT-REPLACEMENT THERAPY FOR PRIMARY HYPOTHYROIDISM: A BRIEF GUIDE FOR CLINICAL PRACTICE.
    Guglielmi R; Frasoldati A; Zini M; Grimaldi F; Gharib H; Garber JR; Papini E
    Endocr Pract; 2016 Nov; 22(11):1319-1326. PubMed ID: 27482609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of thyroid-stimulating hormone levels to development of dyslipidemia and determination of an ideal cut-off point to start replacement therapy.
    Sarzosa Terán V; Astudillo Calle MA
    Endocrinol Nutr; 2012 Dec; 59(10):575-82. PubMed ID: 23036934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?
    Ettleson MD; Bianco AC
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3090-104. PubMed ID: 32614450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
    Shimon I; Cohen O; Lubetsky A; Olchovsky D
    Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyroid hormone treatment].
    Gärtner R
    Dtsch Med Wochenschr; 2014 Feb; 139(9):448. PubMed ID: 24558002
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thyroid hormone treatment].
    Pommer P
    Dtsch Med Wochenschr; 2014 Feb; 139(9):448. PubMed ID: 24558001
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial.
    Bolk N; Visser TJ; Nijman J; Jongste IJ; Tijssen JG; Berghout A
    Arch Intern Med; 2010 Dec; 170(22):1996-2003. PubMed ID: 21149757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters.
    Jonklaas J; Burman KD
    Thyroid; 2016 Jun; 26(6):770-8. PubMed ID: 27030088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone replacement - a counterblast to guidelines.
    Toft AD
    J R Coll Physicians Edinb; 2017 Dec; 47(4):307-309. PubMed ID: 29537398
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination therapy in a hypothyroid patient intolerant of elevated thyroxine.
    Singer AJ
    Clin Cornerstone; 2005; 7 Suppl 2():S20-1. PubMed ID: 16399241
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment for congenital hypothyroidism: thyroxine alone or thyroxine plus triiodothyronine?
    Cassio A; Cacciari E; Cicognani A; Damiani G; Missiroli G; Corbelli E; Balsamo A; Bal M; Gualandi S
    Pediatrics; 2003 May; 111(5 Pt 1):1055-60. PubMed ID: 12728088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-T4 and L-T3 combined treatment vs L-T4 alone.
    Wiersinga WM
    Ann Endocrinol (Paris); 2007 Sep; 68(4):216-9. PubMed ID: 17689474
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy.
    Saberi M; Utiger RD
    J Clin Endocrinol Metab; 1974 Nov; 39(5):923-7. PubMed ID: 4422006
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Replacement treatment of hypothyroidism.
    N Engl J Med; 1974 Jul; 291(2):100-3. PubMed ID: 4209471
    [No Abstract]   [Full Text] [Related]  

  • 18. Current recommendations in the management of hypothyroidism: developed from a statement by the British Thyroid Association Executive.
    Parretti H; Okosieme O; Vanderpump M
    Br J Gen Pract; 2016 Oct; 66(651):538-40. PubMed ID: 27688516
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism.
    Fadeyev VV; Morgunova TB; Melnichenko GA; Dedov II
    Hormones (Athens); 2010; 9(3):245-52. PubMed ID: 20688622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism?
    Biondi B; Wartofsky L
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2256-71. PubMed ID: 22593590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.